カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のニチノールベース心臓病向け介入装置市場2022年：ステント、ガイドワイヤー、その他

◆英語タイトル：Global Nitinol-based Interventional Cardiology Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8212）◆商品コード：GIR22MY8212
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：110
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ニチノールベース心臓病向け介入装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニチノールベース心臓病向け介入装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニチノールベース心臓病向け介入装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ステント、ガイドワイヤー、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界のニチノールベース心臓病向け介入装置市場の主要な市場プレーヤーは以下のとおりです。
・Abbott、Edwards Lifesciences、Medtronic、Boston Scientific、TERUMO、BD、Stryker、Cook Medical、Cordis、B. Braun、Biotronik、MicroPort、JOTEC、Acandis、ELLA-CS

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニチノールベース心臓病向け介入装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニチノールベース心臓病向け介入装置メーカーの企業概要、2019年～2022年までのニチノールベース心臓病向け介入装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニチノールベース心臓病向け介入装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニチノールベース心臓病向け介入装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニチノールベース心臓病向け介入装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニチノールベース心臓病向け介入装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニチノールベース心臓病向け介入装置の産業チェーンを掲載しています。
・第13、14、15章では、ニチノールベース心臓病向け介入装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Edwards Lifesciences、Medtronic、Boston Scientific、TERUMO、BD、Stryker、Cook Medical、Cordis、B. Braun、Biotronik、MicroPort、JOTEC、Acandis、ELLA-CS
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ステント、ガイドワイヤー、その他
・用途別分析2017年-2028年：病院、クリニック、その他
・ニチノールベース心臓病向け介入装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ニチノールベース心臓病向け介入装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ニチノールベース心臓病向け介入装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ニチノールベース心臓病向け介入装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ニチノールベース心臓病向け介入装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nitinol-based Interventional Cardiology Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nitinol-based Interventional Cardiology Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Nitinol-based Interventional Cardiology Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nitinol-based Interventional Cardiology Devices include Abbott, Edwards Lifesciences, Medtronic, Boston Scientific, and TERUMO, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nitinol-based Interventional Cardiology Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Stents
Guidewires
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Nitinol-based Interventional Cardiology Devices market are listed below:
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
TERUMO
BD
Stryker
Cook Medical
Cordis
B. Braun
Biotronik
MicroPort
JOTEC
Acandis
ELLA-CS
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nitinol-based Interventional Cardiology Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nitinol-based Interventional Cardiology Devices, with price, sales, revenue and global market share of Nitinol-based Interventional Cardiology Devices from 2019 to 2022.
Chapter 3, the Nitinol-based Interventional Cardiology Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nitinol-based Interventional Cardiology Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nitinol-based Interventional Cardiology Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nitinol-based Interventional Cardiology Devices.
Chapter 13, 14, and 15, to describe Nitinol-based Interventional Cardiology Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Nitinol-based Interventional Cardiology Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nitinol-based Interventional Cardiology Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Stents
1.2.3 Guidewires
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nitinol-based Interventional Cardiology Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nitinol-based Interventional Cardiology Devices Market Size & Forecast
1.4.1 Global Nitinol-based Interventional Cardiology Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nitinol-based Interventional Cardiology Devices Sales in Volume (2017-2028)
1.4.3 Global Nitinol-based Interventional Cardiology Devices Price (2017-2028)
1.5 Global Nitinol-based Interventional Cardiology Devices Production Capacity Analysis
1.5.1 Global Nitinol-based Interventional Cardiology Devices Total Production Capacity (2017-2028)
1.5.2 Global Nitinol-based Interventional Cardiology Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nitinol-based Interventional Cardiology Devices Market Drivers
1.6.2 Nitinol-based Interventional Cardiology Devices Market Restraints
1.6.3 Nitinol-based Interventional Cardiology Devices Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Nitinol-based Interventional Cardiology Devices Product and Services
2.1.4 Abbott Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Edwards Lifesciences
2.2.1 Edwards Lifesciences Details
2.2.2 Edwards Lifesciences Major Business
2.2.3 Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Product and Services
2.2.4 Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Nitinol-based Interventional Cardiology Devices Product and Services
2.3.4 Medtronic Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Boston Scientific
2.4.1 Boston Scientific Details
2.4.2 Boston Scientific Major Business
2.4.3 Boston Scientific Nitinol-based Interventional Cardiology Devices Product and Services
2.4.4 Boston Scientific Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 TERUMO
2.5.1 TERUMO Details
2.5.2 TERUMO Major Business
2.5.3 TERUMO Nitinol-based Interventional Cardiology Devices Product and Services
2.5.4 TERUMO Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business
2.6.3 BD Nitinol-based Interventional Cardiology Devices Product and Services
2.6.4 BD Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Stryker
2.7.1 Stryker Details
2.7.2 Stryker Major Business
2.7.3 Stryker Nitinol-based Interventional Cardiology Devices Product and Services
2.7.4 Stryker Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cook Medical
2.8.1 Cook Medical Details
2.8.2 Cook Medical Major Business
2.8.3 Cook Medical Nitinol-based Interventional Cardiology Devices Product and Services
2.8.4 Cook Medical Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cordis
2.9.1 Cordis Details
2.9.2 Cordis Major Business
2.9.3 Cordis Nitinol-based Interventional Cardiology Devices Product and Services
2.9.4 Cordis Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 B. Braun
2.10.1 B. Braun Details
2.10.2 B. Braun Major Business
2.10.3 B. Braun Nitinol-based Interventional Cardiology Devices Product and Services
2.10.4 B. Braun Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Biotronik
2.11.1 Biotronik Details
2.11.2 Biotronik Major Business
2.11.3 Biotronik Nitinol-based Interventional Cardiology Devices Product and Services
2.11.4 Biotronik Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 MicroPort
2.12.1 MicroPort Details
2.12.2 MicroPort Major Business
2.12.3 MicroPort Nitinol-based Interventional Cardiology Devices Product and Services
2.12.4 MicroPort Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 JOTEC
2.13.1 JOTEC Details
2.13.2 JOTEC Major Business
2.13.3 JOTEC Nitinol-based Interventional Cardiology Devices Product and Services
2.13.4 JOTEC Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Acandis
2.14.1 Acandis Details
2.14.2 Acandis Major Business
2.14.3 Acandis Nitinol-based Interventional Cardiology Devices Product and Services
2.14.4 Acandis Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 ELLA-CS
2.15.1 ELLA-CS Details
2.15.2 ELLA-CS Major Business
2.15.3 ELLA-CS Nitinol-based Interventional Cardiology Devices Product and Services
2.15.4 ELLA-CS Nitinol-based Interventional Cardiology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nitinol-based Interventional Cardiology Devices Breakdown Data by Manufacturer
3.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nitinol-based Interventional Cardiology Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Nitinol-based Interventional Cardiology Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Nitinol-based Interventional Cardiology Devices Manufacturer Market Share in 2021
3.5 Global Nitinol-based Interventional Cardiology Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nitinol-based Interventional Cardiology Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nitinol-based Interventional Cardiology Devices Market Size by Region
4.1.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2028)
4.2 North America Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.3 Europe Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.4 Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.5 South America Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
4.6 Middle East and Africa Nitinol-based Interventional Cardiology Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Type (2017-2028)
5.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Type (2017-2028)
5.3 Global Nitinol-based Interventional Cardiology Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nitinol-based Interventional Cardiology Devices Sales in Volume by Application (2017-2028)
6.2 Global Nitinol-based Interventional Cardiology Devices Revenue by Application (2017-2028)
6.3 Global Nitinol-based Interventional Cardiology Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
7.2 North America Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
7.3 North America Nitinol-based Interventional Cardiology Devices Market Size by Country
7.3.1 North America Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
8.2 Europe Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
8.3 Europe Nitinol-based Interventional Cardiology Devices Market Size by Country
8.3.1 Europe Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Nitinol-based Interventional Cardiology Devices Market Size by Region
9.3.1 Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
10.2 South America Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
10.3 South America Nitinol-based Interventional Cardiology Devices Market Size by Country
10.3.1 South America Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Nitinol-based Interventional Cardiology Devices Market Size by Country
11.3.1 Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nitinol-based Interventional Cardiology Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nitinol-based Interventional Cardiology Devices
12.3 Nitinol-based Interventional Cardiology Devices Production Process
12.4 Nitinol-based Interventional Cardiology Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nitinol-based Interventional Cardiology Devices Typical Distributors
13.3 Nitinol-based Interventional Cardiology Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nitinol-based Interventional Cardiology Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nitinol-based Interventional Cardiology Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Nitinol-based Interventional Cardiology Devices Product and Services
Table 6. Abbott Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Edwards Lifesciences Basic Information, Manufacturing Base and Competitors
Table 8. Edwards Lifesciences Major Business
Table 9. Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Product and Services
Table 10. Edwards Lifesciences Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Medtronic Basic Information, Manufacturing Base and Competitors
Table 12. Medtronic Major Business
Table 13. Medtronic Nitinol-based Interventional Cardiology Devices Product and Services
Table 14. Medtronic Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 16. Boston Scientific Major Business
Table 17. Boston Scientific Nitinol-based Interventional Cardiology Devices Product and Services
Table 18. Boston Scientific Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. TERUMO Basic Information, Manufacturing Base and Competitors
Table 20. TERUMO Major Business
Table 21. TERUMO Nitinol-based Interventional Cardiology Devices Product and Services
Table 22. TERUMO Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. BD Basic Information, Manufacturing Base and Competitors
Table 24. BD Major Business
Table 25. BD Nitinol-based Interventional Cardiology Devices Product and Services
Table 26. BD Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Stryker Basic Information, Manufacturing Base and Competitors
Table 28. Stryker Major Business
Table 29. Stryker Nitinol-based Interventional Cardiology Devices Product and Services
Table 30. Stryker Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 32. Cook Medical Major Business
Table 33. Cook Medical Nitinol-based Interventional Cardiology Devices Product and Services
Table 34. Cook Medical Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Cordis Basic Information, Manufacturing Base and Competitors
Table 36. Cordis Major Business
Table 37. Cordis Nitinol-based Interventional Cardiology Devices Product and Services
Table 38. Cordis Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. B. Braun Basic Information, Manufacturing Base and Competitors
Table 40. B. Braun Major Business
Table 41. B. Braun Nitinol-based Interventional Cardiology Devices Product and Services
Table 42. B. Braun Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Biotronik Basic Information, Manufacturing Base and Competitors
Table 44. Biotronik Major Business
Table 45. Biotronik Nitinol-based Interventional Cardiology Devices Product and Services
Table 46. Biotronik Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. MicroPort Basic Information, Manufacturing Base and Competitors
Table 48. MicroPort Major Business
Table 49. MicroPort Nitinol-based Interventional Cardiology Devices Product and Services
Table 50. MicroPort Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. JOTEC Basic Information, Manufacturing Base and Competitors
Table 52. JOTEC Major Business
Table 53. JOTEC Nitinol-based Interventional Cardiology Devices Product and Services
Table 54. JOTEC Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Acandis Basic Information, Manufacturing Base and Competitors
Table 56. Acandis Major Business
Table 57. Acandis Nitinol-based Interventional Cardiology Devices Product and Services
Table 58. Acandis Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. ELLA-CS Basic Information, Manufacturing Base and Competitors
Table 60. ELLA-CS Major Business
Table 61. ELLA-CS Nitinol-based Interventional Cardiology Devices Product and Services
Table 62. ELLA-CS Nitinol-based Interventional Cardiology Devices Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Nitinol-based Interventional Cardiology Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 64. Global Nitinol-based Interventional Cardiology Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Nitinol-based Interventional Cardiology Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Nitinol-based Interventional Cardiology Devices Production Capacity by Company, (Units): 2020 VS 2021
Table 67. Head Office and Nitinol-based Interventional Cardiology Devices Production Site of Key Manufacturer
Table 68. Nitinol-based Interventional Cardiology Devices New Entrant and Capacity Expansion Plans
Table 69. Nitinol-based Interventional Cardiology Devices Mergers & Acquisitions in the Past Five Years
Table 70. Global Nitinol-based Interventional Cardiology Devices Sales by Region (2017-2022) & (Units)
Table 71. Global Nitinol-based Interventional Cardiology Devices Sales by Region (2023-2028) & (Units)
Table 72. Global Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Nitinol-based Interventional Cardiology Devices Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2022) & (Units)
Table 75. Global Nitinol-based Interventional Cardiology Devices Sales by Type (2023-2028) & (Units)
Table 76. Global Nitinol-based Interventional Cardiology Devices Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Nitinol-based Interventional Cardiology Devices Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Nitinol-based Interventional Cardiology Devices Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Nitinol-based Interventional Cardiology Devices Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2022) & (Units)
Table 81. Global Nitinol-based Interventional Cardiology Devices Sales by Application (2023-2028) & (Units)
Table 82. Global Nitinol-based Interventional Cardiology Devices Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Nitinol-based Interventional Cardiology Devices Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Nitinol-based Interventional Cardiology Devices Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Nitinol-based Interventional Cardiology Devices Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Nitinol-based Interventional Cardiology Devices Sales by Country (2017-2022) & (Units)
Table 87. North America Nitinol-based Interventional Cardiology Devices Sales by Country (2023-2028) & (Units)
Table 88. North America Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Nitinol-based Interventional Cardiology Devices Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2022) & (Units)
Table 91. North America Nitinol-based Interventional Cardiology Devices Sales by Type (2023-2028) & (Units)
Table 92. North America Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2022) & (Units)
Table 93. North America Nitinol-based Interventional Cardiology Devices Sales by Application (2023-2028) & (Units)
Table 94. Europe Nitinol-based Interventional Cardiology Devices Sales by Country (2017-2022) & (Units)
Table 95. Europe Nitinol-based Interventional Cardiology Devices Sales by Country (2023-2028) & (Units)
Table 96. Europe Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Nitinol-based Interventional Cardiology Devices Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2022) & (Units)
Table 99. Europe Nitinol-based Interventional Cardiology Devices Sales by Type (2023-2028) & (Units)
Table 100. Europe Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2022) & (Units)
Table 101. Europe Nitinol-based Interventional Cardiology Devices Sales by Application (2023-2028) & (Units)
Table 102. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Region (2017-2022) & (Units)
Table 103. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Region (2023-2028) & (Units)
Table 104. Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2022) & (Units)
Table 107. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Type (2023-2028) & (Units)
Table 108. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2022) & (Units)
Table 109. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales by Application (2023-2028) & (Units)
Table 110. South America Nitinol-based Interventional Cardiology Devices Sales by Country (2017-2022) & (Units)
Table 111. South America Nitinol-based Interventional Cardiology Devices Sales by Country (2023-2028) & (Units)
Table 112. South America Nitinol-based Interventional Cardiology Devices Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Nitinol-based Interventional Cardiology Devices Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2022) & (Units)
Table 115. South America Nitinol-based Interventional Cardiology Devices Sales by Type (2023-2028) & (Units)
Table 116. South America Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2022) & (Units)
Table 117. South America Nitinol-based Interventional Cardiology Devices Sales by Application (2023-2028) & (Units)
Table 118. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Region (2017-2022) & (Units)
Table 119. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Region (2023-2028) & (Units)
Table 120. Middle East & Africa Nitinol-based Interventional Cardiology Devices Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Nitinol-based Interventional Cardiology Devices Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Type (2017-2022) & (Units)
Table 123. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Type (2023-2028) & (Units)
Table 124. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Application (2017-2022) & (Units)
Table 125. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales by Application (2023-2028) & (Units)
Table 126. Nitinol-based Interventional Cardiology Devices Raw Material
Table 127. Key Manufacturers of Nitinol-based Interventional Cardiology Devices Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Nitinol-based Interventional Cardiology Devices Typical Distributors
Table 131. Nitinol-based Interventional Cardiology Devices Typical Customers
List of Figures
Figure 1. Nitinol-based Interventional Cardiology Devices Picture
Figure 2. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Type in 2021
Figure 3. Stents
Figure 4. Guidewires
Figure 5. Others
Figure 6. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Global Nitinol-based Interventional Cardiology Devices Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 11. Global Nitinol-based Interventional Cardiology Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Nitinol-based Interventional Cardiology Devices Sales (2017-2028) & (Units)
Figure 13. Global Nitinol-based Interventional Cardiology Devices Price (2017-2028) & (US$/Unit)
Figure 14. Global Nitinol-based Interventional Cardiology Devices Production Capacity (2017-2028) & (Units)
Figure 15. Global Nitinol-based Interventional Cardiology Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Nitinol-based Interventional Cardiology Devices Market Drivers
Figure 17. Nitinol-based Interventional Cardiology Devices Market Restraints
Figure 18. Nitinol-based Interventional Cardiology Devices Market Trends
Figure 19. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Manufacturer in 2021
Figure 20. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Manufacturer in 2021
Figure 21. Nitinol-based Interventional Cardiology Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Nitinol-based Interventional Cardiology Devices Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Nitinol-based Interventional Cardiology Devices Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2017-2028)
Figure 25. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Region (2017-2028)
Figure 26. North America Nitinol-based Interventional Cardiology Devices Revenue (2017-2028) & (USD Million)
Figure 27. Europe Nitinol-based Interventional Cardiology Devices Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue (2017-2028) & (USD Million)
Figure 29. South America Nitinol-based Interventional Cardiology Devices Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Nitinol-based Interventional Cardiology Devices Revenue (2017-2028) & (USD Million)
Figure 31. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2017-2028)
Figure 32. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Type (2017-2028)
Figure 33. Global Nitinol-based Interventional Cardiology Devices Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2017-2028)
Figure 35. Global Nitinol-based Interventional Cardiology Devices Revenue Market Share by Application (2017-2028)
Figure 36. Global Nitinol-based Interventional Cardiology Devices Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2017-2028)
Figure 38. North America Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2017-2028)
Figure 39. North America Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2017-2028)
Figure 40. North America Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2017-2028)
Figure 41. United States Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2017-2028)
Figure 45. Europe Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2017-2028)
Figure 46. Europe Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2017-2028)
Figure 47. Europe Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2017-2028)
Figure 48. Germany Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Nitinol-based Interventional Cardiology Devices Revenue Market Share by Region (2017-2028)
Figure 57. China Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2017-2028)
Figure 64. South America Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2017-2028)
Figure 65. South America Nitinol-based Interventional Cardiology Devices Sales Market Share by Country (2017-2028)
Figure 66. South America Nitinol-based Interventional Cardiology Devices Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Nitinol-based Interventional Cardiology Devices Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Nitinol-based Interventional Cardiology Devices Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Nitinol-based Interventional Cardiology Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Nitinol-based Interventional Cardiology Devices in 2021
Figure 78. Manufacturing Process Analysis of Nitinol-based Interventional Cardiology Devices
Figure 79. Nitinol-based Interventional Cardiology Devices Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のニチノールベース心臓病向け介入装置市場2022年：ステント、ガイドワイヤー、その他(Global Nitinol-based Interventional Cardiology Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の末梢動脈インターベンション用デバイス市場インサイト及び予測（バルーン拡張カテーテル、ステント）
  • 世界のニチノールベース介入装置市場2022年：ステント、ガイドワイヤー、その他
  • 世界の血管インターベンション医療機器市場2022年：ステント、カテーテル、その他
  • 世界の介入耳鼻咽喉科デバイス市場2022年：高周波ヘッドピース、副鼻腔拡張装置、鼓膜切開チューブ、その他
  • 世界の診断・介入心臓病装置市場2022年：経カテーテル血管造影装置、血管内超音波（IVUS）装置、ガイドワイヤー基盤血管内狭窄評価/フラクショナルフローリザーブ（FFR）装置、心臓内心エコー検査（ICE）装置、光コヒーレンストモグラフィー（OCT）装置、ロボット支援手術装置